Mark Ragosa, CHIEF FINANCIAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 85,682 shares at $41.49 ($3.6M) on 2025-12-08, disclosed to the SEC on 2025-12-10.
Scheduled sale ($3.6M) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $41.49 | 42,841 | $1.8M | 50.0% |
| 2 | $41.49 | 42,841 | $1.8M | 50.0% |
| Total | $41.49 avg | 85,682 | $3.6M | 100% |
| Filing → |
| KNSA | SELL | 2026-01-09 | $503K | — | Filing → |
| KNSA | SELL | 2025-11-14 | $815K | — | Filing → |
| KNSA | SELL | 2025-10-30 | $4K | — | Filing → |